2
Total investments
0
Early stage
2
Mid stage
0
Late stage
10y
Years active
Portfolio
2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Non Executive Board Member
Jul 2018
Capillary Biomedical, Inc. (CapBio) is a medical device startup developing technologies for diabetes management. We aim to dramatically simplify insulin delivery, reducing the burden on both patients and the overall healthcare system.
CapBios first product is the patent-pending SteadiSet infusion set for insulin pump therapy. Its SteadiFlow technology features a kink-proof, super-soft cannula with multi-port delivery designed for reliable and comfortable insulin delivery. Our user-friendly insertion device makes it easy.
The company is based in Irvine, CA and is a spin-out of the Artificial Pancreas Center at the Sidney Kimmel Medical College of Thomas Jefferson University in Philadelphia, PA. This ongoing academic-industry collaboration is focused on improving the comfort, reliability and predictability of insulin infusion therapy. Together, we aim to achieve more consistent and reliable insulin absorption, which will enable people with diabetes to achieve improved blood glucose control.
Non Executive Board Member
Apr 2016
ViCentra BV, Medical Devices, Utrecht
Founded in 2013 in Utrecht, The Netherlands, ViCentra is a leading early stage commercial company focused on the development, manufacturing and commercialisation of the Kaleido insulin pump designed to help people with diabetes live life on their own terms.
Driven by our belief in the power of innovative healthcare products that put the people first and a desire to be meaningfully different, Kaleido aims to reduce the impact that diabetes can have on daily life.
Experience · 2 entries
All (2)
Investments (2)
Board (2)
2018
Non Executive Board Member
Jul 2018
Capillary Biomedical, Inc. (CapBio) is a medical device startup developing technologies for diabetes management. We aim to dramatically simplify insulin delivery, reducing the burden on both patients and the overall healthcare system.
CapBios first product is the patent-pending SteadiSet infusion set for insulin pump therapy. Its SteadiFlow technology features a kink-proof, super-soft cannula with multi-port delivery designed for reliable and comfortable insulin delivery. Our user-friendly insertion device makes it easy.
The company is based in Irvine, CA and is a spin-out of the Artificial Pancreas Center at the Sidney Kimmel Medical College of Thomas Jefferson University in Philadelphia, PA. This ongoing academic-industry collaboration is focused on improving the comfort, reliability and predictability of insulin infusion therapy. Together, we aim to achieve more consistent and reliable insulin absorption, which will enable people with diabetes to achieve improved blood glucose control.
2016
Non Executive Board Member
Apr 2016
ViCentra BV, Medical Devices, Utrecht
Founded in 2013 in Utrecht, The Netherlands, ViCentra is a leading early stage commercial company focused on the development, manufacturing and commercialisation of the Kaleido insulin pump designed to help people with diabetes live life on their own terms.
Driven by our belief in the power of innovative healthcare products that put the people first and a desire to be meaningfully different, Kaleido aims to reduce the impact that diabetes can have on daily life.